Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Alternate approach to traditional CPR saves lives

  • Teenage self-harm linked to problems in later life

  • Unsteady on your feet? Little touches could make all the difference

  • Genes exhibit different behaviours in different stages of development

  • Susceptibility for relapsing major depressive disorder can be calculated

  • Clinical trial could change standard treatment for stroke

  • Criminologists try to solve murder mystery: Who will become a killer?

  • Association between air toxics, childhood autism

  • Human skin cells reprogrammed directly into brain cells

  • Mathematical model shows how brain remains stable during learning

  •